Longitudinal Evaluation of Antibody Kinetics of Vaccinated Patients With Non-mandatory Vaccine Following Administration of a Non-public Marketed Vaccine in the General Population, Real-life Study (ELCAV)

CerbaXpert

Status

Not yet enrolling

Conditions

Vaccination Reaction

Treatments

Biological: Blood collection

Study type

Interventional

Funder types

Other

Identifiers

NCT06373510

ELCAV

Details and patient eligibility

About

The study would make it possible to document more explicitly the evolution of antibody titers at following a non-public vaccination over a large post-vaccination period in the French population .

Analysis of real-life data would enhance knowledge of vaccine response kinetics It would be useful to identify possible early declines requiring doses Similarly, by analyzing antibody kinetics by age, sex, and vaccination status, the would be possible to determine whether there are differences in the immune response between these different sub-groups. In addition, it would provide additional information to assess the real impact of these non-public vaccines in public health and guide vaccine policies.

Enrollment

10,000 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Subject over 18 years of age
Subject presenting to the investigation centre as part of its usual management (prevention, screening, tracking)
Subject who has been vaccinated and/or wishes to be vaccinated
Subject able to understand the purpose of research that has given free and informed express consent
Member or beneficiary of a social security scheme

Exclusion criteria